Anakinra
| EAS | Nº pacientes | Respuesta terapéutica n (%) |
Efectos adversos n (%) |
Mortalidad n (%) |
|---|---|---|---|---|
LES |
7 |
5 (71,42%) |
3 (43,85%) |
0 |
Still adulto |
34 |
29 (85,29%) |
11 (32,35%) |
1 (2,94%) |
Policondritis |
1 |
1 (100%) |
0 |
0 |
TOTAL |
42 |
35 (85,33%) |
14 (33,33%) |
1 (2,38%) |